Safety, Tolerability and Efficacy Study of the New Medication ASK8007 to Treat Patients With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the safety and tolerability of the new medication
ASK8007, and to study whether it has a beneficial effect on joint inflammation in patients
with rheumatoid arthritis.